HK Stock Market Move | Chaozhou Three-Circle (Group)(06951) rose nearly 14% in the afternoon, MLCC product prices rebounded, and net profit for the first half of the year is expected to increase by 45%-65%.
Sanhuan Group (06951) rose nearly 14% in the afternoon, up 11.49% by the end of trading, at 100.9 Hong Kong dollars, with a turnover of 1.22 billion Hong Kong dollars.
Chaozhou Three-Circle (Group) (06951) rose nearly 14% in the afternoon, as of the time of publication, it was up 11.49% at HK$100.9, with a turnover of HK$122 million.
On the news front, Chaozhou Three-Circle (Group) announced that it expects a net profit of RMB 1.794 billion to RMB 2.041 billion in the first half of 2026, an increase of 45%-65% from the same period last year. In addition, the company plans to repurchase A-shares, with a total repurchase amount of no less than RMB 450 million and not exceeding RMB 900 million, and the repurchase price not exceeding RMB 135 per share.
During the reporting period, benefiting from the increased demand for electronic components and optical communications industry, the company's main business products saw an increase in demand. In particular, the company's MLCC products benefited from increased customer recognition and industry prosperity, with some specifications prices restored to their original reasonable value, and sales volume and revenue saw a significant year-on-year increase; at the same time, due to the accelerated construction process of global data centers, the demand for optical devices in the market continues to increase, and sales of related optical communication products, such as connectors and sleeves, saw a year-on-year increase.
Related Articles

Shanghai Shen Lian Biomedical Corporation (688098.SH): The swine pseudorabies live vaccine (strain JS-A1) has obtained the approval number for veterinary drug products.
Nayuki (02150) repurchased 1.2805 million shares at a cost of HK$927,700 on July 21st.

CTR HOLDINGS (01416) proposes to issue 275 million shares at a premium of approximately 22.22% to acquire a construction company in Singapore.
Shanghai Shen Lian Biomedical Corporation (688098.SH): The swine pseudorabies live vaccine (strain JS-A1) has obtained the approval number for veterinary drug products.

Nayuki (02150) repurchased 1.2805 million shares at a cost of HK$927,700 on July 21st.
CTR HOLDINGS (01416) proposes to issue 275 million shares at a premium of approximately 22.22% to acquire a construction company in Singapore.

RECOMMEND





